Combined transplantation of heart and liver from two different donors in a patient with familial type IIa hypercholesterolemia. 1986

D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos

A 12-year-old child with terminal ischemic heart disease as a result of homozygotous familial type IIa hypercholesterolemia received an orthotopic heart transplant and, 21 days later, an orthotopic liver transplant. Six months after heart transplantation, the patient is asymptomatic and evidences normal liver function and cholesterol levels; there are no signs of heart rejection. To our knowledge, this is the first instance of two-step heart-liver transplantation with organs from different donors.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos
December 2001, Clinical transplantation,
D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos
September 1985, Nutrition reviews,
D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos
February 1988, Annals of internal medicine,
D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos
February 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos
January 1987, Journal of clinical apheresis,
D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos
January 2015, The Pan African medical journal,
D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos
January 1983, Acta medica Scandinavica,
D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos
January 1979, Journal of lipid research,
D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos
June 2012, Journal of cardiovascular translational research,
D Figuera, and J Ardaiz, and V Martín-Júdez, and L A Pulpón, and G Pradas, and V Cuervas-Mons, and R Burgos, and M Arcas, and F Pardo, and J A Cienfuegos
March 2010, Indian journal of pediatrics,
Copied contents to your clipboard!